HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Vaage Selected Research

Prostatic Neoplasms (Prostate Cancer)

9/2002A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer. First report from the Scandinavian Prostatic Cancer Group Study No. 6.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Vaage Research Topics

Disease

1Gynecomastia
01/2003
1Prostatic Neoplasms (Prostate Cancer)
09/2002
1Disease Progression
09/2002

Drug/Important Bio-Agent (IBA)

1Androgen Antagonists (Antiandrogens)IBA
01/2003
1bicalutamide (Casodex)FDA LinkGeneric
09/2002

Therapy/Procedure

1Therapeutics
09/2002